Gufic Biosciences Limited (BOM:509079)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical and Related Products	9.44B	8.20B	8.07B	6.91B	7.79B
Total	9.44B	8.20B	8.07B	6.91B	7.79B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	7.27B	6.54B	7.19B	5.84B	7.07B
Africa	268.90M	241.44M	98.75M	134.14M	90.89M
Asia	651.82M	495.54M	363.02M	511.62M	281.23M
Europe	894.19M	617.81M	296.40M	294.23M	255.21M
North America	320.69M	97.45M	102.38M	116.19M	83.53M
Australia	4.67M	6.25M	2.02M	5.36M	4.06M
South America	29.63M	194.70M	18.89M	7.50M	6.24M
Total	9.44B	8.20B	8.07B	6.91B	7.79B

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 14, 2026

Data Sources Report a data error